alendronate has been researched along with Gastritis in 5 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The anti-catabolic bisphosphonate alendronate is considered as the first-line medical treatment in post-menopausal osteoporosis; but several side effects, including gastric mucosal injury, are associated with its use." | 7.91 | Melatonin supports alendronate in preserving bone matrix and prevents gastric inflammation in ovariectomized rats. ( Akkiprik, M; Çilingir-Kaya, ÖT; Ercan, F; Gürler, EB; Peker Eyüboglu, I; Reiter, RJ; Yegen, BÇ, 2019) |
| "The anti-catabolic bisphosphonate alendronate is considered as the first-line medical treatment in post-menopausal osteoporosis; but several side effects, including gastric mucosal injury, are associated with its use." | 3.91 | Melatonin supports alendronate in preserving bone matrix and prevents gastric inflammation in ovariectomized rats. ( Akkiprik, M; Çilingir-Kaya, ÖT; Ercan, F; Gürler, EB; Peker Eyüboglu, I; Reiter, RJ; Yegen, BÇ, 2019) |
| "Alendronate does not cause predictable esophageal, gastric, or duodenal mucosal damage when used as directed." | 2.69 | Upper gastrointestinal toxicity of alendronate. ( Depew, WT; Lowe, CE; Meddings, JB; Paterson, WG; Vanner, SJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gürler, EB | 1 |
| Çilingir-Kaya, ÖT | 1 |
| Peker Eyüboglu, I | 1 |
| Ercan, F | 1 |
| Akkiprik, M | 1 |
| Reiter, RJ | 1 |
| Yegen, BÇ | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Parfitt, JR | 1 |
| Driman, DK | 1 |
| Downs, RW | 1 |
| Bone, HG | 1 |
| McIlwain, H | 1 |
| Baker, MZ | 1 |
| Yates, AJ | 1 |
| Lombardi, A | 1 |
| Krupa, D | 1 |
| Harning, R | 1 |
| Lowe, CE | 1 |
| Depew, WT | 1 |
| Vanner, SJ | 1 |
| Paterson, WG | 1 |
| Meddings, JB | 1 |
1 review available for alendronate and Gastritis
| Article | Year |
|---|---|
Pathological effects of drugs on the gastrointestinal tract: a review.
Topics: Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Colitis; Drug-Related Side Effects | 2007 |
2 trials available for alendronate and Gastritis
| Article | Year |
|---|---|
An open-label extension study of alendronate treatment in elderly women with osteoporosis.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density; Do | 1999 |
Upper gastrointestinal toxicity of alendronate.
Topics: Adult; Aged; Alendronate; Double-Blind Method; Dyspepsia; Female; Gastric Mucosa; Gastritis; Gastros | 2000 |
2 other studies available for alendronate and Gastritis
| Article | Year |
|---|---|
Melatonin supports alendronate in preserving bone matrix and prevents gastric inflammation in ovariectomized rats.
Topics: Alendronate; Animals; Bone Matrix; Female; Gastritis; Inflammation; Melatonin; Osteoporosis; Ovariec | 2019 |
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents | 2010 |